CYP26B1 and neoplasm: Comparing CYP26B1 negative tumours with tumours that showed any CYP26B1 immunoreactivity then poorer survival was associated with CYP26B1 expression (HR = 1.352, 95%CI = 1.054–1.735, χ2 = 5.707, p = 0.017).